Brief: Metir Says Pathogen Detector Phase 2 Progressing With Aptamer Towards Planned Commercialisation In Early 2027
28/09/2026 07:41
BRIEF-Metir Says Pathogen Detector Phase 2 Progressing With Aptamer Towards Planned Commercialisation In Early 2027 Sept 28 (Reuters) - Metir PLC METME.L:
METIR PLC - INTERIM RESULTS FOR SIX MONTHS ENDED 30 JUNE 2026
METIR PLC: DEVELOPING A NEW ANTIBODY MASS PRODUCTION METHOD TO MEET ALL MARKET DEMAND STARTING IN Q1 2027
METIR PLC: PATHOGEN DETECTOR PHASE 2 IS PROGRESSING WITH APTAMER GROUP TOWARDS PLANNED COMMERCIALISATION IN EARLY 2027
Source text: ID:nRSb5305Wa
Further company coverage: METME.L